FDA全球物质注册数据库（FDA Global Substance Registration System）
物质名称RAVAGALIMAB
异名/同义词ABBV-323
IMMUNOGLOBULIN G1, (ANTI-HUMAN CD19 (ANTIGEN)) (HUMANIZED CLONE RB4V1.2 .GAMMA.1-CHAIN), DISULFIDE WITH HUMANIZED CLONE RB4V1.2 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G1, ANTI-(HUMAN CD40 ANTIGEN) (HUMANIZED MOUSE MONOCLONAL PR-1629977 .GAMMA.1-CHAIN), DISULFIDE WITH HUMANIZED MOUSE MONOCLONAL PR-1629977 .KAPPA.-CHAIN, DIMER
PR-1629977
RAVAGALIMAB
RAVAGALIMAB [INN]
RAVAGALIMAB [USAN]
CAS登记号2050816-56-1
物质唯一标识(Unique Ingredient Identifier)YGF9TW3QZJ
分子式
国际化合物标识(International Chemical Identifier,InChI)
SMILES
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / protein
关联数据
  • 药品国际非专利名称数据库
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System